title: Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysis.
authors.affiliation: University of Michigan School of Medicine, Ann Arbor, Michigan.
authors.forename: Bertram
authors.initials: B
authors.lastname: Pitt
authors.affiliation: Inserm 9501 and 1116, Centre d'Investigations Cliniques, Nancy, France; CHU Nancy, Institut Lorrain du Coeur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France; Université de Lorraine, Nancy, France; Association Lorraine pour le Traitement de l'Insuffisance Rénale, Vandoeuvre lès Nancy, Nancy, France. Electronic address: p.rossignol@chu-nancy.fr.
authors.forename: Patrick
authors.initials: P
authors.lastname: Rossignol
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use*
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone
keywords: cardiovascular and cerebrovascular event; hemodialysis; spironolactone